GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Milestone Scientific Inc (AMEX:MLSS) » Definitions » Beneish M-Score

Milestone Scientific (Milestone Scientific) Beneish M-Score : -3.74 (As of May. 16, 2024)


View and export this data going back to 1995. Start your Free Trial

What is Milestone Scientific Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -3.74 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Milestone Scientific's Beneish M-Score or its related term are showing as below:

MLSS' s Beneish M-Score Range Over the Past 10 Years
Min: -6.41   Med: -3.3   Max: -2.06
Current: -3.74

During the past 13 years, the highest Beneish M-Score of Milestone Scientific was -2.06. The lowest was -6.41. And the median was -3.30.


Milestone Scientific Beneish M-Score Historical Data

The historical data trend for Milestone Scientific's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Milestone Scientific Beneish M-Score Chart

Milestone Scientific Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4.27 -2.61 -2.90 -3.71 -3.74

Milestone Scientific Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.71 -3.31 -3.70 -3.75 -3.74

Competitive Comparison of Milestone Scientific's Beneish M-Score

For the Medical Instruments & Supplies subindustry, Milestone Scientific's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Milestone Scientific's Beneish M-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Milestone Scientific's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Milestone Scientific's Beneish M-Score falls into.



Milestone Scientific Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Milestone Scientific for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.4041+0.528 * 0.8053+0.404 * 0.9754+0.892 * 1.1161+0.115 * 0.8079
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.9406+4.679 * -0.140872-0.327 * 1.095
=-3.74

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Total Receivables was $0.31 Mil.
Revenue was 2.261 + 2.059 + 2.91 + 2.598 = $9.83 Mil.
Gross Profit was 1.51 + 1.503 + 1.89 + 1.889 = $6.79 Mil.
Total Current Assets was $10.79 Mil.
Total Assets was $11.37 Mil.
Property, Plant and Equipment(Net PPE) was $0.37 Mil.
Depreciation, Depletion and Amortization(DDA) was $0.15 Mil.
Selling, General, & Admin. Expense(SGA) was $13.14 Mil.
Total Current Liabilities was $3.08 Mil.
Long-Term Debt & Capital Lease Obligation was $0.28 Mil.
Net Income was -1.939 + -1.466 + -2.216 + -1.308 = $-6.93 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = $0.00 Mil.
Cash Flow from Operations was -1.246 + -1.053 + -1.024 + -2.004 = $-5.33 Mil.
Total Receivables was $0.69 Mil.
Revenue was 2.241 + 2.216 + 1.648 + 2.701 = $8.81 Mil.
Gross Profit was 1.085 + 1.453 + 0.681 + 1.682 = $4.90 Mil.
Total Current Assets was $12.97 Mil.
Total Assets was $13.70 Mil.
Property, Plant and Equipment(Net PPE) was $0.48 Mil.
Depreciation, Depletion and Amortization(DDA) was $0.15 Mil.
Selling, General, & Admin. Expense(SGA) was $12.51 Mil.
Total Current Liabilities was $3.30 Mil.
Long-Term Debt & Capital Lease Obligation was $0.40 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(0.313 / 9.828) / (0.694 / 8.806)
=0.031848 / 0.07881
=0.4041

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(4.901 / 8.806) / (6.792 / 9.828)
=0.556552 / 0.691087
=0.8053

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (10.794 + 0.374) / 11.372) / (1 - (12.971 + 0.479) / 13.702)
=0.017939 / 0.018391
=0.9754

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=9.828 / 8.806
=1.1161

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(0.145 / (0.145 + 0.479)) / (0.151 / (0.151 + 0.374))
=0.232372 / 0.287619
=0.8079

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(13.137 / 9.828) / (12.514 / 8.806)
=1.336691 / 1.421077
=0.9406

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((0.282 + 3.077) / 11.372) / ((0.396 + 3.3) / 13.702)
=0.295375 / 0.269742
=1.095

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-6.929 - 0 - -5.327) / 11.372
=-0.140872

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Milestone Scientific has a M-score of -3.74 suggests that the company is unlikely to be a manipulator.


Milestone Scientific Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Milestone Scientific's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Milestone Scientific (Milestone Scientific) Business Description

Traded in Other Exchanges
N/A
Address
425 Eagle Rock Avenue, Roseland, NJ, USA, 07068
Milestone Scientific Inc is engaged in pioneering proprietary, technological systems, and solutions for the medical and dental markets. It develops, manufactures, markets and sells the computer-controlled system for the improved and painless delivery of local anesthetic. The system is marketed in dentistry under the trademark CompuDent and in medicine under the trademark CompuMed. In addition, the company provides The Wand, a handpiece that allows dentists to provide painless injections for virtually various dental procedures, including routine cleanings and fillings, as well as implants, root canals, and crowns. The Company conducts its business through two reportable segments: Dental and Medical. Geographically all the operations of the firm function through the region of the U.S.
Executives
Peter J Milligan officer: President 1650 TYSONS BOULEVARD, SUITE 1700, MCLEAN VA 22102
Neal I Goldman director 170 SOUTHPORT DRIVE, MORRISVILLE NC 27560
Leslie Bernhard director C/O ADSTAR, INC., 488 S. ROYAL LANE, COPPELL TX 75019
Benedetta I Casamento director 200 CAMPUS DRIVE, FLORHAM PARK NJ 07932
Leonard Osser director, 10 percent owner, officer: CEO
Leonard M Schiller director
Scott L. Kahn officer: Chief Financial Officer 425 EAGLE ROCK AVENUE, SUITE 403, ROSELAND NJ 07068
Giandomenico Trombetta director, 10 percent owner CORSO VENEZIA 44, MILAN L6 20121
Joseph D'agostino officer: CFO & COO C/O MILESTONE SCIENTIFIC INC., 220 SOUTH ORANGE AVENUE, LIVINGSTON NJ 07039
Jan Adriaan Haverhals officer: President 110 WHITE ROCK ROAD, APT. 3304, VERONA NJ 07044
Brent W Johnston officer: President C/O MILESTONE SCIENTIFIC INC., 220 SOUTH ORANGE AVENUE SUITE 102, LIVINGSTON NJ 07039
Michael Mcgeehan director C/O MILESTONE SCIENTIFIC INC, LIVINGSTON NJ 07039
Edward J. Zelnick director C/O MILESTONE SCIENTIFIC INC., 220 SOUTH ORANGE AVENUE, LIVINGSTON NJ 07039
Daniel S Goldberger officer: President and CEO 24 CARPENTER ROAD, CHESTER NY 10918
Bp4 S.r.l. director, 10 percent owner, officer: See Remarks CORSO VENEZIA 44, MILAN L6 20121

Milestone Scientific (Milestone Scientific) Headlines

From GuruFocus